← back to search

Thomas V. Riley

University of Wollongong · AU
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Clostridium difficile, Biology, Medicine, Microbiology, Chemistry, and Peptidomimetic.
h-index
citations
1,774
works
25
NIH funding
primary concept
email

Recent publications

Positional Isomers of Biphenyl Antimicrobial Peptidomimetic Amphiphiles
ACS Medicinal Chemistry Letters 2021cited by 13position: middledoi
Cationic Peptidomimetic Amphiphiles Having a N-Aryl- or N-Naphthyl-1,2,3-Triazole Core Structure Targeting Clostridioides (Clostridium) difficile: Synthesis, Antibacterial Evaluation, and an In Vivo C. difficile Infection Model
Antibiotics 2021cited by 11position: middledoi
Adaptation of host transmission cycle during Clostridium difficile speciation
Nature Genetics 2019cited by 59position: middledoi
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies
European Journal of Medicinal Chemistry 2019cited by 34position: middledoi
Different molecular characteristics and antimicrobial resistance profiles of <i>Clostridium difficile</i> in the Asia-Pacific region
Emerging Microbes & Infections 2019cited by 25position: middledoi
Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model
European Journal of Medicinal Chemistry 2019cited by 22position: middledoi
Reducing length of stay to improve Clostridium difficile-related health outcomes
Infection Disease & Health 2018cited by 10position: middledoi
Economic evaluation of interventions designed to reduce Clostridium difficile infection
PLoS ONE 2018cited by 7position: middledoi
Zoonotic Transfer of Clostridium difficile Harboring Antimicrobial Resistance between Farm Animals and Humans
Journal of Clinical Microbiology 2017cited by 175position: middledoi
Clostridium difficile infection in the Lao People’s Democratic Republic: first isolation and review of the literature
BMC Infectious Diseases 2017cited by 12position: middledoi
Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection
Journal of Clinical Gastroenterology 2016cited by 81position: middledoi
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages
Journal of Clinical Microbiology 2016cited by 62position: middledoi
Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional study
Clinical Microbiology and Infection 2016cited by 29position: lastdoi
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications
BMC Infectious Diseases 2015cited by 203position: middledoi
Clostridium difficile Infection Seasonality: Patterns across Hemispheres and Continents – A Systematic Review
PLoS ONE 2015cited by 52position: middledoi
Mechanisms of hypervirulent Clostridium difficile ribotype 027 displacement of endemic strains: an epidemiological model
Scientific Reports 2015cited by 48position: middledoi
Synthesis and antimicrobial activity of binaphthyl-based, functionalized oxazole and thiazole peptidomimetics
Organic & Biomolecular Chemistry 2015cited by 39position: middledoi
Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria
Organic & Biomolecular Chemistry 2015cited by 33position: middledoi
25‐Hydroxyvitamin D Concentrations and <i>Clostridium difficile</i> Infection: A Meta‐Analysis
Journal of Parenteral and Enteral Nutrition 2015cited by 18position: middledoi
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired <i>Clostridium difficile</i> Infection: A Systematic Review and Meta-analysis
Infection Control and Hospital Epidemiology 2014cited by 162position: middledoi
Removal of Pathogens by Membrane Bioreactors: A Review of the Mechanisms, Influencing Factors and Reduction in Chemical Disinfectant Dosing
Water 2014cited by 145position: middledoi
Synthesis of Mono and Bis[60]fullerene‐Based Dicationic Peptoids
European Journal of Organic Chemistry 2014cited by 11position: middledoi
Phage ϕC2 Mediates Transduction of Tn <i>6215</i> , Encoding Erythromycin Resistance, between Clostridium difficile Strains
mBio 2013cited by 94position: middledoi
Clostridium difficile infection in the community: a zoonotic disease?
Clinical Microbiology and Infection 2012cited by 293position: middledoi
Macro and Micro Diversity of Clostridium difficile Isolates from Diverse Sources and Geographical Locations
PLoS ONE 2012cited by 136position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Archie C. A. Clements · Australian National University9 papers (2014–2018)Laith Yakob · London School of Hygiene & Tropical Medicine9 papers (2014–2018)Paul A. Keller · University of Wollongong7 papers (2014–2021)Luis Furuya‐Kanamori · University of Queensland7 papers (2014–2016)Stephen G. Pyne · University of Wollongong7 papers (2014–2021)David L. Paterson · Department of Public Health7 papers (2014–2016)Katherine A. Hammer · The University of Western Australia6 papers (2014–2021)Andrew J. Tague · University of Wollongong6 papers (2015–2021)Ed J. Kuijper · National Center for Infectious Diseases5 papers (2012–2019)Samantha J. McKenzie · University of Queensland4 papers (2014–2016)Papanin Putsathit · The University of Western Australia4 papers (2019–2021)Dena Lyras · University of California, Davis4 papers (2015–2021)Brendan W. Wren · London School of Hygiene & Tropical Medicine4 papers (2012–2019)Steven M. Wales · University of Wollongong4 papers (2015–2019)Trevor D. Lawley · Wellcome Sanger Institute3 papers (2016–2019)Daniel R. Knight · University of Leicester3 papers (2019–2021)Charlotte Huber · University of Queensland3 papers (2015–2016)J. Glenn Songer · University of Arizona2 papers (2012–2017)J. Scott Weese · Tufts University2 papers (2016–2017)Adrian Barnett · Twitter (United States)2 papers (2018–2018)